Prospect Capital Corporation (Nasdaq:PSEC) announced that Prospect has made a senior subordinated debt investment of $14 million to support the acquisition of Royal Adhesives & Sealants LLC ("Royal") by Arsenal Capital Partners. Royal is a leading producer of proprietary, high-performance adhesives and sealants.
Headquartered in South Bend, Indiana, the company offers a broad range of specialty formulated products designed to solve complex bonding, laminating, and sealing applications across a diverse range of markets, including aerospace and defense, construction, specialty packaging, automotive, and industrial.
Prospect Capital Corporation (prospectstreet.com) is a closed-end investment company that lends to and invests in private and microcap public businesses. Our investment objective is to generate both current income and long-term capital appreciation through debt and equity investments.
POWER 3 MEDICAL PRODUCTS (OTC BB: PWRM.OB)
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers.
With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.
Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops.
Power3 Medical Products, Inc ., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD ) in Honolulu, Hawaii.
These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
Alzheimer's disease isn't an ordinary part of getting older, even though greatest known risk factor is increasing age, along with the largest part of people today with Alzheimer's tend to be 65 and older.
But Alzheimer's is not just a sickness of old age.
Up to 5 % of people with the sickness currently have early-onset Alzheimer's (also referred to as younger-onset), which frequently appears when ever someone is within his or her 40s or 50s.
Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. Power3 Medical Products, Inc . was founded in 1992 and is based in The Woodlands, Texas.
To learn more about PWRM visit: http://www.Power3Medical.com
NVIDIA Corporation (Nasdaq:NVDA) announced that NVIDIA® SLI® technology has been licensed by the world's leading motherboard manufacturers -- including Intel, ASUS, Gigabyte, MSI and EVGA -- for use on their Intel P67 Express Chipset-based motherboards designed for the upcoming Intel® Sandy Bridge processors.
NVIDIA awakened the world to the power of computer graphics when it invented the GPU in 1999. Since then, it has consistently set new standards in visual computing with breathtaking, interactive graphics available on devices ranging from tablets and portable media players to notebooks and workstations.
Caribou Coffee Company, Inc. (Nasdaq:CBOU) announced that its majority shareholder, Caribou Holding Company Limited, an affiliate of Arcapita Bank B.S.C. (c), is offering for sale 5,000,000 shares of the Company’s common stock in an underwritten public offering. The selling shareholder has also granted the underwriters an option to purchase up to 750,000 additional shares of common stock to cover over-allotments, if any. The Company will not receive any proceeds from the offering.
Caribou Coffee Company, Inc., founded in 1992 and headquartered in Minneapolis, Minnesota, is the second largest company-owned premium coffeehouse operator in the United States based on the number of coffeehouses. For more information, visit the Caribou Coffee web site at www.cariboucoffee.com.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).